Overview

Ventricular Drainage Overview:

FutureWise Market Research has illustrated a report that provides an in-depth anatomy of Ventricular Drainage Sets Market trends affecting its growth. Moreover, it includes intricate insights on profitability graph, market share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of this market.

The Ventricular Drainage Sets Market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Ventricular Drainage Sets Market are:   
• Integra LifeSciences Corporation
• Medtronic plc
• Fuji Systems Corporation
• Moller Medical GmbH
• Sophysa
• Dispomedica
• Spiegelberg GmbH & Co. KG.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Ventricular Drainage Sets Market Segmentation:
By Product Type
• Ventricular Drainage Set
• Accessories (catheters and external ventricular drainage bag)

By Application
• Intraventricular Hemorrhage
• Intracranial Hypertension
• Hydrocephalus
• CSF Infection
• Others

By End User
• Hospitals
• Ambulatory Surgical Centers

By Region
• North America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Ventricular Drainage Sets Market by product type, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Introduction 
          1.1 Objectives of the Study 
          1.2 Market Definition 
          1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
          1.4 Currency 
          1.5 Limitations 
          1.6 Stakeholders 
 2.  Research Methodology 
      2.1 Research Data 
         2.1.1 Secondary Data
                 2.1.1.1 Key Data From Secondary Sources
         2.1.2 Primary Data
                 2.1.2.1 Key Data From Primary Sources
      2.2 Market Size Estimation 
      2.3 Market Breakdown and Data Triangulation 
      2.4 Assumptions for the Study  
3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Global Ventricular Drainage Sets Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards And Compliances
5. Market Overview
     5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Ventricular Drainage Sets Market Analysis Tools
         6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Global Ventricular Drainage Sets Market, By Product Type Historical Analysis and Forecast 2021-2028 (USD Million)
   7.1. Ventricular Drainage Set
   7.2. Accessories (catheters and external ventricular drainage bag)
8. Global Ventricular Drainage Sets Market, By Application Historical Analysis and Forecast 2021-2028 (USD Million)
   8.1. Intraventricular Hemorrhage
   8.2. Intracranial Hypertension
   8.3. Hydrocephalus
   8.4. CSF Infection
   8.5. Others
9. Global Ventricular Drainage Sets Market, By End User Historical Analysis and Forecast 2021-2028 (USD Million)
   9.1. Hospitals
   9.2. Ambulatory Surgical Centers
10.  North America Ventricular Drainage Sets Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
     10.1. Introduction
     10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            10.2.1. U.S.A
            10.2.2. Canada
     10.3. Market Size (USD Million) Forecast for North America 2021-2028
11. Europe Ventricular Drainage Sets Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
     11.1. Introduction
     11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
            11.2.1. Germany
            11.2.2. U.K
           11.2.3. France
           11.2.4. Italy
           11.2.5. Spain
           11.2.6. Russia
           11.2.7. Poland
           11.2.8. Switzerland
           11.2.10.Rest of Western Europe
12. Asia Pacific Ventricular Drainage Sets Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million) with expected regulatory needs
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
             12.2.1. Japan
             12.2.2. China
             12.2.3. Singapore
             12.2.4. India
             12.2.5. Australia and New Zealand
             12.2.6. ASEAN
             12.2.7. South Korea
             12.2.8. Rest of Asia Pacific
        12.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028
13. Rest of the World Ventricular Drainage Sets Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
             13.2.1. Saudi Arabia
             13.2.2. UAE
             13.2.3. South Africa
             13.2.4. Egypt
        13.3. Market Size (USD Million) Forecast for MEA 2021-2028
14. Market Share Analysis and Competitive Landscape   
    14.1. Global Landscape - Key Players, Revenue and Presence
    14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    14.3. Global Emerging Companies
    14.4. North America - Market Share Analysis and Key Regional Players
    14.5. Europe - Market Share Analysis and Key Regional Players
    14.6. Asia Pacific - Market Share Analysis and Key Regional Players
    14.7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
         15.1. Integra LifeSciences Corporation
                15.1.1. Company Overview
                15.1.2. Product Portfolio 
                15.1.3. SWOT Analysis
                15.1.4. Financial Overview
                15.1.5. Strategic Overview
         15.2. Dispomedica 
                15.2.1. Company Overview
                15.2.2. Product Portfolio
                15.2.3. SWOT Analysis
                15.2.4. Financial Overview
                15.2.5. Strategic Overview
         15.3. Spiegelberg GmbH 
                15.3.1. Company Overview
                15.3.2. Product Portfolio
                15.3.3. SWOT Analysis
                15.3.4. Financial Overview
                15.3.5. Strategic Overview
         15.4. Medtronic
                15.4.1. Company Overview
                15.4.2. Product Portfolio
                15.4.3. SWOT Analysis
                15.4.4. Financial Overview
                15.4.5. Strategic Overview
         15.5. Sophysa
                15.5.1. Company Overview
                15.5.2. Product Portfolio
                15.5.3. SWOT Analysis
                15.5.4. Financial Overview
                15.5.5. Strategic Overview
         15.6. Fuji Systems Corporation
                15.6.1. Company Overview
                15.6.2. Product Portfolio
                15.6.3. SWOT Analysis
                15.6.4. Financial Overview
                15.6.5. Strategic Overview
         15.7. Moller Medical GmbH
                15.7.1. Company Overview
                15.7.2. Product Portfolio
                15.7.3. SWOT Analysis
                15.7.4. Financial Overview
                15.7.5. Strategic Overview
16. Pre and Post COVID-19 Impact
    16.1. Positive influence on the healthcare industry
    16.2. The financial disruption of the manufacturing sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the healthcare regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client
 

Tables

Figures